Site Map
Posts
- Category: Wp Feeds (continued)
- D.C. Week: More $$ Still Needed for Zika, Says NIAID Director
- D.C. Week: Mostly Smooth Sailing for FDA Nominee at Senate Hearing
- D.C. Week: Mylan CEO Grilled at Hearing; Internal FDA Spat
- D.C. Week: NOAC Reversal Drug Stalls at FDA
- D.C. Week: Obama Moves to Curb Opioid Abuse
- D.C. Week: Obama Pitches $1.1 Billion to Fight Opioid Addiction
- D.C. Week: Obama Releases FY 2017 Budget
- D.C. Week: Obama Sets Task Force to Ensure Access to Addiction Tx
- D.C. Week: Obama Vetoes ACA Repeal
- D.C. Week: Obamacare and Planned Parenthood Get Axed by Senate
- D.C. Week: Obamacare Days Appear Numbered
- D.C. Week: Officials to Congress: Help Needed for Overdose Fight
- D.C. Week: Partisan Jousting Marks Price Hearing for HHS Post
- D.C. Week: Possible MACRA Delay; Opioid Bill Passes
- D.C. Week: Second PCSK9 Inhibitor Wins FDA Approval
- D.C. Week: Senate Confirms Price for HHS Job
- D.C. Week: Senator Places Hold on Califf's FDA Nomination
- D.C. Week: Senators, CMS Official Spar on Part B Proposal
- D.C. Week: Soaring Drug Prices in Spotlight at Senate Hearing
- D.C. Week: Supreme Court Hears Subsidies Case
- D.C. Week: Surgeon General Calls Addiction a Medical Condition
- D.C. Week: Trump Inaugurated as 45th President
- D.C. Week: Trump Shares Broad Outline of Trumpcare
- D.C. Week: Trump Taps Price for HHS; Medicaid Expert to Run CMS
- D.C. Week: Trump, House GOP Trying Again for ACA Repeal
- D.C. Week: Turing Execs Grilled Again in Senate Hearing
- D.C. Week: Two Novel Opioids Win Tepid Backing From FDA Panel
- D.C. Week: War on Cancer Redux
- D.C. Week: ‘Bionic Pancreas’ OK’d
- DAA Era Linked with Better Liver Transplant Outcomes
- Daily Aspirin Cuts Colorectal Cancer in High-Risk Adults (CME/CE, with audio)
- Danoprevir Combo Cuts Hep C Viral Load (CME/CE)
- Data Dump: U.S. Trials Often Fail to Report Results (CME/CE)
- Data Lacking on Fecal DNA Test, Agency Says
- Data Point to Safer Bariatric Surgery (CME/CE)
- Day One: Trump Begins ACA Take Down
- DDW 2015: Hep C Tx and Microbiome Top Agenda
- DDW 2017: Diversity Will Be Meeting's Strength
- DDW 2017: Diversity Will Be Meeting's Strength
- DDW Roundup: Constipation, Celiac Disease, Gastroparesis
- DDW: Biologics Change the Course of Inflammatory Bowel Disease (with video)
- DDW: Biologics Linger in Moms-to-be With IBD (CME/CE)
- DDW: Caregivers for the Chronically Ill at High Risk for IBS (CME/CE)
- DDW: Celiac Disease Often Goes Untreated (CME/CE)
- DDW: Cholinesterase Blocker Helps in Dyspepsia (CME/CE)
- DDW: Colonoscopy Thrives Despite Insurer Coverage of CT Screens (CME/CE)
- DDW: Cut Carbs to Avoid Gallstones in Pregnancy (CME/CE)
- DDW: Depression, Pain Linked in Kids' IBD (CME/CE)
- DDW: Doubt Cast on Promising IBD Target (CME/CE)
- DDW: Drug Cuts IV Nutrition Needs in Short Bowel (CME/CE)
